Reposition
JSB-Partners offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. JSB-Partners works closely with clients to deliver impactful business and corporate development resources and expertise. To meet clients needs, the firm offers strategic analyses, targeted selection of and communications with potential transaction parties, proven negotiation skills, and other services needed to drive transactions to a successful closing. Their exclusive partnership with Noble Financial Capital Markets allows them to deliver a complete range of corporate finance services.
JSB Partners - Recent News & Articles
The Impact of Two Consumer Classes and the Fed Funds Rate Outlook
Investing.com -- The Federal Reserve may need to implement more aggressive rate cuts as recent data reveals a concerning trend in the labor market, ac...
For two long years private companies have spurned public markets, as rising interest rates dashed lofty valuations and stock prices vacillated. All th...
The volume of deals worldwide valued at more than $100 million plunged 37% to just 280 during the first half of this year, undercut by rising interest...
Investment bankers’ advisory fees have plunged to the lowest level in almost a decade because of a prolonged slowdown in deal activity. Fees for compl...
SVB Financial Group, the former parent company of Silicon Valley Bank, has entered into an agreement to sell its investment banking business, SVB Secu...
Mizuho Financial Group is forging further into U.S. investment banking through a deal to buy Greenhill & Co. as it seeks to accelerate growth. The Jap...
Federal Reserve Chair Jerome Powell finds himself in a difficult place that no central banker wants to be: working to avert a credit crunch, which cal...
Bank stocks are often perceived to be a harbinger of broader economic trends so BankerAdvisor wheeled around some of the big banks’ reported second qu...